2 Biotech Stocks Set to Rebound in 2026
Looking to beat the market over the next five years? Here's one strategy to adopt: Invest in stocks that have not performed well recently but boast attractive prospects.
Two intriguing corporations to consider now are Viking Therapeutics (NASDAQ: VKTX) and BioNTech (NASDAQ: BNTX). These biotech companies are somewhat risky, but after terrible performances in 2025, both could rebound this year and deliver strong returns through 2031. Allow me to explain.
Image source: Getty Images.
Source Fool.com
Viking Therapeutics Inc Stock
€25.29
-0.200%
Currently there is a rather positive sentiment for Viking Therapeutics Inc with 4 Buy predictions and 0 Sell predictions.
However, we have a potential of -1.15% for Viking Therapeutics Inc as the target price of 25 € is below the current price of 25.29 €.
